Skip to main content
Timothy Gilligan, MD, Oncology, Cleveland, OH, Cleveland Clinic

TimothyDavidGilliganMDFASCO, FACH

Oncology Cleveland, OH

Genitourinary Oncology

President, Academy of Communication in Healthcare. Associate Professor of Medicine, Cleveland Clinic Lerner College of Medicine. Vice-Chair for Education, Taussig Cancer Institute. DEI Officer for Graduate Medical Education, Cleveland Clinic

Dr. Gilligan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Gilligan's full profile

Already have an account?


  • I am a medical oncologist specializing in testis cancer and other genitourinary malignancies. I currently chair the Testicular Cancer guideline panel at the National Comprehensive Cancer Network. A major focus of my work is teaching communication-skills to clinicians, as well as training others to teach communication skills. At the Cleveland Clinic, I helped develop and served on the leadership team of the Center for Excellence for Healthcare Communication where we have trained over 8000 clinicians in fundamental healthcare communication skills and have trained over 50 clinicians as trainers. I will serve as President of the Academy on Communication in Healthcare (ACH) for 2023 and 2024, and I was previously co-directer of the ACH faculty training program. At the Cleveland Clinic Lerner College of Medicine, I am the Associate Director of the communication skills course for first and second year medical students. Recently my work has focused on increasing Diversity, Equity, and Inclusion in healthcare and I am currently the DEI Officer for Graduate Medical Education at Cleveland Clinic.

    I have taught communication skills to clinicians at national and international conferences and meetings of major organizations including the ACGME, AAMC, IHI, ASCO, and ACH. In addition to relationship-centered communication skills, workshops that I have led have focused on coaching, conflict engagement, team-building and feedback.

    I also work in graduate medical education. I was program director of the hematology/oncology fellowship at Cleveland Clinic for ten years and currently serve as DEI Officer for GME at Cleveland Clinic and vice-Chair for Education at the Clinic's Taussig Cancer Institute.

Education & Training

  • Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute1999 - 2001
  • Brigham and Women's Hospital
    Brigham and Women's HospitalResidency, Internal Medicine, 1996 - 1999
  • Stanford University School of Medicine
    Stanford University School of MedicineClass of 1996

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 2005 - 2025
  • MA State Medical License
    MA State Medical License 1998 - 2005
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Fellow Academy on Communication in Healthcare, 2020
  • Fellow American Society of Clinical Oncology, 2017
  • Scholarship in Teaching Award Case Western Reserve School of Medicine, 2015
  • Join now to see all

Publications & Presentations


Journal Articles

  • The Association Between Facility Case Volume and Overall Survival in Patients with Metastatic Renal Cell Carcinoma in the Targeted Therapy Era  
    Timothy Gilligan, Jorge A Garcia, Brian I Rini, Urologic Oncology
  • Treatment Selection for Men with Metastatic Prostate Cancer Who Progress on Upfront Chemo‐Hormonal Therapy  
    Vadim Koshkin, Prateek Mendiratta, Brian I Rini, Pedro Barata, Christos Kyriakopoulos, Hamid Emamekhoo, Timothy Gilligan, The Prostate

Books/Book Chapters

  • Join now to see all


  • Patient-Clinician Communication: Implementing the New ASCO Consensus Guideline. 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018


Authored Content

  • Trespass and Forgiveness9/16/2018
  • The Dangerous Intimacy of Life8/23/2018
  • Blind Spots8/15/2018
  • The Power of Questions8/7/2018
  • Communication as Performance8/1/2018
  • Join now to see all

Press Mentions

  • Do Brain Metastases Rule Out Immunotherapy in RCC?
    Do Brain Metastases Rule Out Immunotherapy in RCC?June 11th, 2019
  • Effect of Anti-Angiogenesis/Immunotherapy Combo in Poor-Risk RCC
    Effect of Anti-Angiogenesis/Immunotherapy Combo in Poor-Risk RCCJune 10th, 2019
  • Patient Outcomes for Atezolizumab vs Sunitinib in Renal Cell Carcinoma
    Patient Outcomes for Atezolizumab vs Sunitinib in Renal Cell CarcinomaJune 10th, 2019
  • Join now to see all

Professional Memberships

  • American Society of Clinical Oncology
  • Academy on Communication in Healthcare
    Board Member
  • Academy on Communication in Healthcare

Hospital Affiliations